What are the Supplementary Tables that assess the effect of CCB versus CCB in patients with CKD without DM?
Supplementary Table 30, Supplementary Table 31, Supplementary Table 32, Supplementary Table 33, Supplementary Table 34, Supplementary Table 35, and Supplementary Table 36 all assess the effect of CCB versus CCB in patients with CKD without DM. Supplementary Table 30 and Supplementary Table 31 assess categorical outcomes, while Supplementary Table 32 and Supplementary Table 33 assess continuous outcomes. Supplementary Table 34 and Supplementary Table 35 assess general population RCTs comparing ACEI diuretic versus placebo in CKD with DM subgroups, and Supplementary Table 36 assesses general population RCTs comparing CCB versus active control in CKD subgroups with and without DM.